The MCG reports through the Center for Nanoscience (CNS) which directly reports to the Vice Chancellor of Research at UMSL. The MCG is also forging strong partnerships with the Department of Chemistry & Biochemistry. This reporting structure has 4 distinct advantages: 1) scientists are employed directly through the MCG rather than academic departments, freeing them to focus on developing new therapies for unmet medical needs; 2) as an independent entity, the MCG can respond more rapidly to shifting research priorities dictated by the most recent and promising data, yet maintain an institutional memory of expertise in specific disease areas; 3) MCG staffing can increase efficiently and prudently as funding sources increase; 4) the model still allows MCG scientists to effectively share the benefits of close collaborative interactions with the basic research community in the University.